Literature DB >> 32379643

Efficacy and safety of moxibustion for chronic low back pain: A systematic review and meta-analysis of randomized controlled trials.

Feng-Qin Chen1, Jian-Feng Ge2, Yu-Fei Leng1, Cheng Li1, Bin Chen1, Zhi-Ling Sun3.   

Abstract

INTRODUCTION: To systematically review and meta-analyze the efficacy of moxibustion in treating patients with chronic low back pain (CLBP).
METHODS: A systematic search of the Cochrane Library, Web of Science, PubMed, Embase, EBSCO, CBM, Wanfang, CNKI and VIP (until November, 2019) was used to identify studies reporting pain intensity (VAS or NRS), disability (ODI or RMDQ), JOA score, and quality of life (SF-36) in patients with CLBP. Study selection, data extraction was performed critically and independently by two reviewers. Cochrane criteria for risk of bias was used to assess the methodological quality of the trials. The Grading of Recommendations Assessment, Development, and Evaluation Methodology (GRADE) was applied to test the quality of evidence from the quantitative analysis.
RESULTS: Ten RCTs, including 987 patients, met the inclusion criteria. Moxibustion had a superior effect on VAS score when compared with western medicine [RR = -1.69, 95%CI(-2.40, -0.98), p < 0.00001] and acupuncture [RR = -0.47, 95%CI(-0.92, -0.02), p=0.04], but it failed to do so when compared with core stability training [RR = -0.41, 95%CI(-0.87, 0.05), p=0.08]. The result showed that moxibustion plus other active treatments (including western medicine, massage, acupuncture and core stability training) had better effects on low back pain relief compared with active treatments alone. Moxibustion showed favourable effects on disability [SMD = -3.80, 95%CI (-5.49, -2.11), p < 0.0001], JOA score [MD = 4.10, 95%CI(2.30, 5.90), p < 0.00001], and SF-36 score [MD = 13.41, 95%CI(9.68, 17.14), p < 0.00001]. The evidence level of the results from the ten studies was determined to be very low to low.
CONCLUSIONS: It is difficult to draw firm conclusions that moxibustion is an effective intervention for treating CLBP due to the small sample size of eligible trails and the high risk of bias among the available articles. Rigorously designed large-scale RCTs are required to further confirm the results in this review.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chronic low back pain; Meta-analysis; Moxibustion; Systematic review

Year:  2020        PMID: 32379643     DOI: 10.1016/j.ctcp.2020.101130

Source DB:  PubMed          Journal:  Complement Ther Clin Pract        ISSN: 1744-3881            Impact factor:   2.446


  5 in total

Review 1.  The Effect and Safety of Thunder-Fire Moxibustion for Low Back Pain: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Yao Yao; Lin Zhou; Feng-Qin Chen; Rui Zhang; Xiang-Tian Pang; Yu-Fei Leng; Xiao Xu; Zhi-Ling Sun
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-18       Impact factor: 2.650

2.  Grain-sized moxibustion promotes NK cell antitumour immunity by inhibiting adrenergic signalling in non-small cell lung cancer.

Authors:  Dan Hu; Weiming Shen; Chenyuan Gong; Cheng Fang; Chao Yao; Xiaowen Zhu; Lixin Wang; Chen Zhao; Shiguo Zhu
Journal:  J Cell Mol Med       Date:  2021-01-27       Impact factor: 5.310

3.  Efficacy of warming needle moxibustion in the treatment of ankylosing spondylitis: A protocol of a randomized controlled trial.

Authors:  Weizhong Ding; Shirong Chen; Xuexiang Shi; Yang Zhao
Journal:  Medicine (Baltimore)       Date:  2021-05-21       Impact factor: 1.817

4.  A Meta-Analysis of the Effect of Subthalamic Nucleus-Deep Brain Stimulation in Parkinson's Disease-Related Pain.

Authors:  Yu Diao; Yutong Bai; Tianqi Hu; Zixiao Yin; Huangguang Liu; Fangang Meng; Anchao Yang; Jianguo Zhang
Journal:  Front Hum Neurosci       Date:  2021-07-01       Impact factor: 3.169

Review 5.  Understanding Traditional Chinese Medicine Therapeutics: An Overview of the Basics and Clinical Applications.

Authors:  Luís Carlos Matos; Jorge Pereira Machado; Fernando Jorge Monteiro; Henry Johannes Greten
Journal:  Healthcare (Basel)       Date:  2021-03-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.